OrthoPediatrics (NASDAQ:KIDS) reported Q4 EPS of ($0.35), $0.12 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $30.99 million versus the consensus estimate of $32.86 million.
GUIDANCE:
OrthoPediatrics sees FY2023 revenue of $146-149 million, versus the consensus of $148.79 million.